Literature DB >> 1640518

Biodegradable pericardial implants for bladder augmentation: a 2.5-year study in dogs.

H Kambic1, R Kay, J F Chen, M Matsushita, H Harasaki, S Zilber.   

Abstract

Bladder augmentation using biodegradable pericardial tissue was evaluated in canine bladders. Acetic acid and acetic anhydride treated pericardial tissue grafts were stored in 75% ethanol for 18 to 27 months before implant. Ten dogs weighing 20 to 25 kg. were subjected to a 50% partial cystectomy. After careful separation of the mucosa, bladder muscle and adventitial layers a pericardial graft volumetrically equivalent to the portion of the bladder removed was sutured to the bladder remnant in 2 layers. In 1 control dog the bladder was opened, 50% of the bladder was removed and the bladder was closed primarily. In another control dog the excised bladder was replaced with fresh chemically treated patch material that was never subjected to ethanol storage. Excretory urography and cystography were performed on all dogs. Urodynamics with filling pressures and bladder volumes measured before and after the operation at intervals of up to 36 months confirmed that adequate bladder capacity was achieved. There were no operative complications. Postmortem histological evaluations revealed a smooth epithelialized inner surface with no traces of any surface irregularities or suture lines. The bladder apex showed an intact epithelium and the absence of a smooth muscle layer. The biodegradable acetylated tissue provides an intact structural reservoir for urine and serves as a template for epithelial regeneration. This permits volumetric bladder enlargement while the graft is progressively reabsorbed with time.

Entities:  

Mesh:

Year:  1992        PMID: 1640518     DOI: 10.1016/s0022-5347(17)36649-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Long-term follow-up and evaluation of autoaugmentation cystoplasty (detrusorotomy) in an animal model.

Authors:  C Taneli; A Genç
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

2.  Tissue engineering in urology.

Authors:  Derek J Matoka; Earl Y Cheng
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

Review 3.  Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder.

Authors:  Fatemeh Ajalloueian; Greg Lemon; Jöns Hilborn; Ioannis S Chronakis; Magdalena Fossum
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

4.  Bladder reconstruction using bovine pericardium in a case of enterovesical fistula.

Authors:  Seung Jin Moon; Dai Hee Kim; Jung Ki Jo; Jae Hoon Chung; Joo Yong Lee; Sung Yul Park; Yong Tae Kim; Hwon Kyum Park; Hong Yong Choi; Hong Sang Moon
Journal:  Korean J Urol       Date:  2011-02-21

5.  Tissue-engineered cholecyst-derived extracellular matrix: a biomaterial for in vivo autologous bladder muscular wall regeneration.

Authors:  Abdol-Mohammad Kajbafzadeh; Shabnam Sabetkish; Reza Heidari; Maryam Ebadi
Journal:  Pediatr Surg Int       Date:  2014-01-28       Impact factor: 1.827

Review 6.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

Review 7.  Silk Fibroin Scaffolds for Urologic Tissue Engineering.

Authors:  Bryan S Sack; Joshua R Mauney; Carlos R Estrada
Journal:  Curr Urol Rep       Date:  2016-02       Impact factor: 3.092

8.  The use of silver nitrate for chemical de-epithelialization and urothelialization of intestine in a rabbit model of augmentation cystoplasty.

Authors:  Savaş Demirbilek; Sema Uğuralp; Necla Gürbüz; Nurzen Sezgin; Hale Kirimlioğlu
Journal:  Urol Res       Date:  2003-06-12

9.  Cystometric analysis of the transplanted bladder.

Authors:  Jeová Nina Rocha
Journal:  Int Braz J Urol       Date:  2017 Jan-Feb       Impact factor: 1.541

Review 10.  The evolution of bladder augmentation: from creating a reservoir to reconstituting an organ.

Authors:  Roman Jednak
Journal:  Front Pediatr       Date:  2014-02-10       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.